Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
kccfpaq-gggsk-fitc
- Development stage
- Phase 1
- Lead developer
- University of Michigan
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Peptide-Drug Conjugates → Peptide Conjugates → Peptides
- Administration
- Topical
01
Overview
KCCFPAQ-GGGSK-FITC is a synthetic, fluorescently labeled heptapeptide probe designed for targeted detection of human colon cancer. The peptide sequence (KCCFPAQ) was identified via phage display screening against human colorectal cancer cells and specifically binds to the cell surface protein peroxiredoxin 1 (Prdx1), which is overexpressed in certain colorectal neoplasms. The GGGSK linker separates the peptide from the FITC fluorophore to minimize steric hindrance and optimize binding. This agent has been evaluated in preclinical animal models and early-phase clinical studies for its safety and utility as a topical imaging agent during colonoscopy, aiming to improve detection of sessile serrated adenomas and other precancerous lesions[1][2][4].
- Other names
- KCCFPAQ-GGGSK-FITCKCC*-FITC5-FITC-labeled colon-heptapeptide
02
Targets
PRDX1 (Peroxiredoxin-1)
Beyond the preview
Go deeper on kccfpaq-gggsk-fitc.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on kccfpaq-gggsk-fitc.